The medical far infrared therapy device market in Canada is projected to grow at a 5.1% CAGR from 2025 to 2031, fueled by rising demand for non-invasive pain relief, increased awareness of health benefits, and adoption of home healthcare solutions. Portable devices and pain management applications are leading growth, supported by technological advances like smart controls and remote monitoring. Opportunities exist in rehabilitation, sports medicine, dermatology, and wound care, with manufacturers expanding product lines and partnerships to enhance market reach. Challenges include high costs and regulatory hurdles, but urban markets and aging populations will drive continued expansion.
Canada Medical Far Infrared Therapy Device Market growth context is provided here for readers. For those tracking health-sector stocks on Pluang, 51 of 150 US-listed health stocks rose while 94 fell as of Nov 06, 2026 20:42 WIB. Notable moves include XRAY at USD 8.68 down 13.97%, TMDX at USD 77.21 up 11.93% with 100% buy order activity, and BKD at USD 9.55 down 11.66%.
Kendal Nutricare Limited will be referred to government and state agencies after refusing to participate in a compliance inquiry by the BBB National Programs’ National Advertising Division. The inquiry followed a challenge by Abbott Laboratories rega...
The Mexico animal healthcare market is projected to grow from $2.13 billion in 2025 to $3.34 billion by 2031, at a CAGR of 7.84%. Growth is fueled by rising spending on companion animals, expanding livestock production, and innovations in veterinary ...
Rainforest Distribution Corp. has implemented Samsara Route Planning and Commercial Navigation across its direct-store-delivery fleet, unifying routing, navigation, telematics, and compliance on one platform integrated with its SAP system. This upgra...
BriaCell Therapeutics and its subsidiary BriaPro presented positive preclinical data at the SITC 2026 Annual Meeting, highlighting their immunotherapy platforms Bria-OTS+ and BP-80. Bria-OTS+ showed broad immune activation and sustained cancer cell k...
Canary Capital has launched the Canary Staked INJ ETF (INJC) on Nasdaq, providing investors exposure to INJ, the native token of the Injective blockchain. The ETF not only tracks INJ's price but also earns staking rewards from the network's proof-of-...
